Accès à distance ? S'identifier sur le proxy UCLouvain
Therapy using labelled somatostatin analogues : comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche – Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't |
---|---|
Access type | Accès restreint |
Publication date | 2008 |
Language | Anglais |
Journal information | "Nuclear Medicine Communications" - Vol. 29, no. 3, p. 283-290 (2008) |
Peer reviewed | yes |
Publisher | Lippincott Williams & Wilkins ((United States) Philadelphia) |
issn | 0143-3636 |
e-issn | 1473-5628 |
Publication status | Publié |
Affiliations |
UCL
- MD/MINT - Département de médecine interne UCL - (SLuc) Service de médecine nucléaire |
MESH Subject | Adult ; Aged ; Female ; Humans ; Indium Radioisotopes - pharmacokinetics - therapeutic use ; Male ; Middle Aged ; Neuroendocrine Tumors - metabolism - radiotherapy - secondary ; Octreotide - analogs & derivatives - pharmacokinetics - therapeutic use ; Pentetic Acid - analogs & derivatives - pharmacokinetics - therapeutic use ; Radiation Dosage ; Radiopharmaceuticals - diagnostic use - pharmacokinetics ; Relative Biological Effectiveness ; Somatostatin - analogs & derivatives - pharmacokinetics - therapeutic use |
Links |
Bibliographic reference | Barone, Raffaella ; Walrand, Stéphan ; Konijnenberg, Mark ; Valkema, Roelf ; Kvols, Larry K ; et. al. Therapy using labelled somatostatin analogues : comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide. In: Nuclear Medicine Communications, Vol. 29, no. 3, p. 283-290 (2008) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/12746 |